Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAMD4A antisense RNA 1 (SAMD4A-AS1) is a long noncoding RNA transcribed from the antisense strand of the SAMD4A gene locus. As a lncRNA, it does not code for protein. There is no known functional or clinical significance established for SAMD4A-AS1 in the literature or in the results provided. Its name indicates it is a transcript related to, but distinct from, the SAMD4A gene, which codes for a conserved RNA-binding protein involved in post-transcriptional regulation, translational repression, and antiviral response[3][1]. The functional role and disease relevance of SAMD4A-AS1 remain uncharacterized to date. Notes: - SAMD4A-AS1 is not the same as SAMD4A protein; functional data for the protein (a RNA-binding protein with roles in translational repression and antiviral defense) should not be conflated with its antisense noncoding RNA[1][3]. - No evidence is present in the results or mainstream databases that directly implicate SAMD4A-AS1 in human disease or as a therapeutic target, nor is it validated as a regulatory lncRNA similar to better-studied antisense lncRNAs[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SAMD4A antisense RNA 1 (SAMD4A-AS1).